Global Hunter Syndrome Therapeutic Market Research Report 2023

December 2023 | 86 pages | ID: G8224AEE6EFEEN
QYResearch

Abstracts

Hunter’s syndrome is a very rare inherited genetic disorder which primarily affects males. When left untreated, Hunter syndrome is potentially lethal and leads to a shorter life span of the individuals diagnosed. There are various clinical trials being conducted by market players for the development of new Hunter syndrome Treatment, especially the neurological symptoms and complications.

According to QYResearch’s new survey, global Hunter Syndrome Therapeutic market is projected to reach US$ 1868.2 million in 2029, increasing from US$ 1256 million in 2022, with the CAGR of 5.8% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Hunter Syndrome Therapeutic market research.

The Hunter Syndrome Therapeutic market is driven by the need to provide effective treatments for individuals affected by Hunter syndrome, a rare genetic disorder. Therapeutic interventions, such as enzyme replacement therapies, aim to alleviate the symptoms of the disease and improve the quality of life for patients. The increasing awareness of rare diseases and the growing emphasis on personalized medicine contribute to market growth. Moreover, advancements in biotechnology and gene therapy offer promising avenues for developing novel treatments. However, challenges include the high cost of therapeutic interventions, which can limit accessibility for some patients, and the complexity of developing therapies that address the diverse spectrum of symptoms associated with Hunter syndrome. Navigating regulatory approvals and ensuring the long-term safety and efficacy of therapeutic options are ongoing concerns. The market's success relies on sustained research efforts, collaborations among researchers, clinicians, and pharmaceutical companies, and the development of innovative, accessible, and patient-centric treatment strategies for Hunter syndrome.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Hunter Syndrome Therapeutic market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

• Takeda
• Denali Therapeutics
• ArmaGen
• Inventiva
• Green Cross Corp
• CANbridge Life Sciences Ltd.
• JCR Pharmaceuticals
• REGENXBIO
• Sangamo Therapeutics

Segment by Type

• Intravenous
• Intracerebroventricular (ICV)

Segment by Application

• Hospital
• Clinic
• Other

By Region

• North America
• United States
• Canada
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Nordic Countries
• Rest of Europe
• Asia-Pacific
• China
• Japan
• South Korea
• Southeast Asia
• India
• Australia
• Rest of Asia
• Latin America
• Mexico
• Brazil
• Rest of Latin America
• Middle East & Africa
• Turkey
• Saudi Arabia
• UAE
• Rest of MEA

The Hunter Syndrome Therapeutic report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)

Chapter 2: Global market size, regional market size. Market Opportunities and Challenges

Chapter 3: Companies’ Competition Patterns

Chapter 4: Product Type Analysis

Chapter 5: Product Application Analysis

Chapter 6 to 10: Country Level Value Analysis

Chapter 11: Companies’ Outline

Chapter 12: Market Conclusions

Chapter 13: Research Methodology and Data Source

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Market Analysis by Type
  1.2.1 Global Hunter Syndrome Therapeutic Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
  1.2.2 Intravenous
  1.2.3 Intracerebroventricular (ICV)
1.3 Market by Application
  1.3.1 Global Hunter Syndrome Therapeutic Market Growth by Application: 2018 VS 2022 VS 2029
  1.3.2 Hospital
  1.3.3 Clinic
  1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered

2 GLOBAL GROWTH TRENDS

2.1 Global Hunter Syndrome Therapeutic Market Perspective (2018-2029)
2.2 Hunter Syndrome Therapeutic Growth Trends by Region
  2.2.1 Global Hunter Syndrome Therapeutic Market Size by Region: 2018 VS 2022 VS 2029
  2.2.2 Hunter Syndrome Therapeutic Historic Market Size by Region (2018-2023)
  2.2.3 Hunter Syndrome Therapeutic Forecasted Market Size by Region (2024-2029)
2.3 Hunter Syndrome Therapeutic Market Dynamics
  2.3.1 Hunter Syndrome Therapeutic Industry Trends
  2.3.2 Hunter Syndrome Therapeutic Market Drivers
  2.3.3 Hunter Syndrome Therapeutic Market Challenges
  2.3.4 Hunter Syndrome Therapeutic Market Restraints

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Hunter Syndrome Therapeutic Players by Revenue
  3.1.1 Global Top Hunter Syndrome Therapeutic Players by Revenue (2018-2023)
  3.1.2 Global Hunter Syndrome Therapeutic Revenue Market Share by Players (2018-2023)
3.2 Global Hunter Syndrome Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Hunter Syndrome Therapeutic Revenue
3.4 Global Hunter Syndrome Therapeutic Market Concentration Ratio
  3.4.1 Global Hunter Syndrome Therapeutic Market Concentration Ratio (CR5 and HHI)
  3.4.2 Global Top 10 and Top 5 Companies by Hunter Syndrome Therapeutic Revenue in 2022
3.5 Hunter Syndrome Therapeutic Key Players Head office and Area Served
3.6 Key Players Hunter Syndrome Therapeutic Product Solution and Service
3.7 Date of Enter into Hunter Syndrome Therapeutic Market
3.8 Mergers & Acquisitions, Expansion Plans

4 HUNTER SYNDROME THERAPEUTIC BREAKDOWN DATA BY TYPE

4.1 Global Hunter Syndrome Therapeutic Historic Market Size by Type (2018-2023)
4.2 Global Hunter Syndrome Therapeutic Forecasted Market Size by Type (2024-2029)

5 HUNTER SYNDROME THERAPEUTIC BREAKDOWN DATA BY APPLICATION

5.1 Global Hunter Syndrome Therapeutic Historic Market Size by Application (2018-2023)
5.2 Global Hunter Syndrome Therapeutic Forecasted Market Size by Application (2024-2029)

6 NORTH AMERICA

6.1 North America Hunter Syndrome Therapeutic Market Size (2018-2029)
6.2 North America Hunter Syndrome Therapeutic Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Hunter Syndrome Therapeutic Market Size by Country (2018-2023)
6.4 North America Hunter Syndrome Therapeutic Market Size by Country (2024-2029)
6.5 United States
6.6 Canada

7 EUROPE

7.1 Europe Hunter Syndrome Therapeutic Market Size (2018-2029)
7.2 Europe Hunter Syndrome Therapeutic Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Hunter Syndrome Therapeutic Market Size by Country (2018-2023)
7.4 Europe Hunter Syndrome Therapeutic Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries

8 ASIA-PACIFIC

8.1 Asia-Pacific Hunter Syndrome Therapeutic Market Size (2018-2029)
8.2 Asia-Pacific Hunter Syndrome Therapeutic Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Hunter Syndrome Therapeutic Market Size by Region (2018-2023)
8.4 Asia-Pacific Hunter Syndrome Therapeutic Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia

9 LATIN AMERICA

9.1 Latin America Hunter Syndrome Therapeutic Market Size (2018-2029)
9.2 Latin America Hunter Syndrome Therapeutic Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Hunter Syndrome Therapeutic Market Size by Country (2018-2023)
9.4 Latin America Hunter Syndrome Therapeutic Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil

10 MIDDLE EAST & AFRICA

10.1 Middle East & Africa Hunter Syndrome Therapeutic Market Size (2018-2029)
10.2 Middle East & Africa Hunter Syndrome Therapeutic Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Hunter Syndrome Therapeutic Market Size by Country (2018-2023)
10.4 Middle East & Africa Hunter Syndrome Therapeutic Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE

11 KEY PLAYERS PROFILES

11.1 Takeda
  11.1.1 Takeda Company Detail
  11.1.2 Takeda Business Overview
  11.1.3 Takeda Hunter Syndrome Therapeutic Introduction
  11.1.4 Takeda Revenue in Hunter Syndrome Therapeutic Business (2018-2023)
  11.1.5 Takeda Recent Development
11.2 Denali Therapeutics
  11.2.1 Denali Therapeutics Company Detail
  11.2.2 Denali Therapeutics Business Overview
  11.2.3 Denali Therapeutics Hunter Syndrome Therapeutic Introduction
  11.2.4 Denali Therapeutics Revenue in Hunter Syndrome Therapeutic Business (2018-2023)
  11.2.5 Denali Therapeutics Recent Development
11.3 ArmaGen
  11.3.1 ArmaGen Company Detail
  11.3.2 ArmaGen Business Overview
  11.3.3 ArmaGen Hunter Syndrome Therapeutic Introduction
  11.3.4 ArmaGen Revenue in Hunter Syndrome Therapeutic Business (2018-2023)
  11.3.5 ArmaGen Recent Development
11.4 Inventiva
  11.4.1 Inventiva Company Detail
  11.4.2 Inventiva Business Overview
  11.4.3 Inventiva Hunter Syndrome Therapeutic Introduction
  11.4.4 Inventiva Revenue in Hunter Syndrome Therapeutic Business (2018-2023)
  11.4.5 Inventiva Recent Development
11.5 Green Cross Corp
  11.5.1 Green Cross Corp Company Detail
  11.5.2 Green Cross Corp Business Overview
  11.5.3 Green Cross Corp Hunter Syndrome Therapeutic Introduction
  11.5.4 Green Cross Corp Revenue in Hunter Syndrome Therapeutic Business (2018-2023)
  11.5.5 Green Cross Corp Recent Development
11.6 CANbridge Life Sciences Ltd.
  11.6.1 CANbridge Life Sciences Ltd. Company Detail
  11.6.2 CANbridge Life Sciences Ltd. Business Overview
  11.6.3 CANbridge Life Sciences Ltd. Hunter Syndrome Therapeutic Introduction
  11.6.4 CANbridge Life Sciences Ltd. Revenue in Hunter Syndrome Therapeutic Business (2018-2023)
  11.6.5 CANbridge Life Sciences Ltd. Recent Development
11.7 JCR Pharmaceuticals
  11.7.1 JCR Pharmaceuticals Company Detail
  11.7.2 JCR Pharmaceuticals Business Overview
  11.7.3 JCR Pharmaceuticals Hunter Syndrome Therapeutic Introduction
  11.7.4 JCR Pharmaceuticals Revenue in Hunter Syndrome Therapeutic Business (2018-2023)
  11.7.5 JCR Pharmaceuticals Recent Development
11.8 REGENXBIO
  11.8.1 REGENXBIO Company Detail
  11.8.2 REGENXBIO Business Overview
  11.8.3 REGENXBIO Hunter Syndrome Therapeutic Introduction
  11.8.4 REGENXBIO Revenue in Hunter Syndrome Therapeutic Business (2018-2023)
  11.8.5 REGENXBIO Recent Development
11.9 Sangamo Therapeutics
  11.9.1 Sangamo Therapeutics Company Detail
  11.9.2 Sangamo Therapeutics Business Overview
  11.9.3 Sangamo Therapeutics Hunter Syndrome Therapeutic Introduction
  11.9.4 Sangamo Therapeutics Revenue in Hunter Syndrome Therapeutic Business (2018-2023)
  11.9.5 Sangamo Therapeutics Recent Development

12 ANALYST'S VIEWPOINTS/CONCLUSIONS


13 APPENDIX

13.1 Research Methodology
  13.1.1 Methodology/Research Approach
  13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Global Hunter Syndrome Therapeutic Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Intravenous
Table 3. Key Players of Intracerebroventricular (ICV)
Table 4. Global Hunter Syndrome Therapeutic Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Hunter Syndrome Therapeutic Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Hunter Syndrome Therapeutic Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Hunter Syndrome Therapeutic Market Share by Region (2018-2023)
Table 8. Global Hunter Syndrome Therapeutic Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Hunter Syndrome Therapeutic Market Share by Region (2024-2029)
Table 10. Hunter Syndrome Therapeutic Market Trends
Table 11. Hunter Syndrome Therapeutic Market Drivers
Table 12. Hunter Syndrome Therapeutic Market Challenges
Table 13. Hunter Syndrome Therapeutic Market Restraints
Table 14. Global Hunter Syndrome Therapeutic Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Hunter Syndrome Therapeutic Market Share by Players (2018-2023)
Table 16. Global Top Hunter Syndrome Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hunter Syndrome Therapeutic as of 2022)
Table 17. Ranking of Global Top Hunter Syndrome Therapeutic Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Hunter Syndrome Therapeutic Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Hunter Syndrome Therapeutic Product Solution and Service
Table 21. Date of Enter into Hunter Syndrome Therapeutic Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Hunter Syndrome Therapeutic Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Hunter Syndrome Therapeutic Revenue Market Share by Type (2018-2023)
Table 25. Global Hunter Syndrome Therapeutic Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Hunter Syndrome Therapeutic Revenue Market Share by Type (2024-2029)
Table 27. Global Hunter Syndrome Therapeutic Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Hunter Syndrome Therapeutic Revenue Market Share by Application (2018-2023)
Table 29. Global Hunter Syndrome Therapeutic Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Hunter Syndrome Therapeutic Revenue Market Share by Application (2024-2029)
Table 31. North America Hunter Syndrome Therapeutic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Hunter Syndrome Therapeutic Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Hunter Syndrome Therapeutic Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Hunter Syndrome Therapeutic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Hunter Syndrome Therapeutic Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Hunter Syndrome Therapeutic Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Hunter Syndrome Therapeutic Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Hunter Syndrome Therapeutic Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Hunter Syndrome Therapeutic Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Hunter Syndrome Therapeutic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Hunter Syndrome Therapeutic Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Hunter Syndrome Therapeutic Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Hunter Syndrome Therapeutic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Hunter Syndrome Therapeutic Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Hunter Syndrome Therapeutic Market Size by Country (2024-2029) & (US$ Million)
Table 46. Takeda Company Detail
Table 47. Takeda Business Overview
Table 48. Takeda Hunter Syndrome Therapeutic Product
Table 49. Takeda Revenue in Hunter Syndrome Therapeutic Business (2018-2023) & (US$ Million)
Table 50. Takeda Recent Development
Table 51. Denali Therapeutics Company Detail
Table 52. Denali Therapeutics Business Overview
Table 53. Denali Therapeutics Hunter Syndrome Therapeutic Product
Table 54. Denali Therapeutics Revenue in Hunter Syndrome Therapeutic Business (2018-2023) & (US$ Million)
Table 55. Denali Therapeutics Recent Development
Table 56. ArmaGen Company Detail
Table 57. ArmaGen Business Overview
Table 58. ArmaGen Hunter Syndrome Therapeutic Product
Table 59. ArmaGen Revenue in Hunter Syndrome Therapeutic Business (2018-2023) & (US$ Million)
Table 60. ArmaGen Recent Development
Table 61. Inventiva Company Detail
Table 62. Inventiva Business Overview
Table 63. Inventiva Hunter Syndrome Therapeutic Product
Table 64. Inventiva Revenue in Hunter Syndrome Therapeutic Business (2018-2023) & (US$ Million)
Table 65. Inventiva Recent Development
Table 66. Green Cross Corp Company Detail
Table 67. Green Cross Corp Business Overview
Table 68. Green Cross Corp Hunter Syndrome Therapeutic Product
Table 69. Green Cross Corp Revenue in Hunter Syndrome Therapeutic Business (2018-2023) & (US$ Million)
Table 70. Green Cross Corp Recent Development
Table 71. CANbridge Life Sciences Ltd. Company Detail
Table 72. CANbridge Life Sciences Ltd. Business Overview
Table 73. CANbridge Life Sciences Ltd. Hunter Syndrome Therapeutic Product
Table 74. CANbridge Life Sciences Ltd. Revenue in Hunter Syndrome Therapeutic Business (2018-2023) & (US$ Million)
Table 75. CANbridge Life Sciences Ltd. Recent Development
Table 76. JCR Pharmaceuticals Company Detail
Table 77. JCR Pharmaceuticals Business Overview
Table 78. JCR Pharmaceuticals Hunter Syndrome Therapeutic Product
Table 79. JCR Pharmaceuticals Revenue in Hunter Syndrome Therapeutic Business (2018-2023) & (US$ Million)
Table 80. JCR Pharmaceuticals Recent Development
Table 81. REGENXBIO Company Detail
Table 82. REGENXBIO Business Overview
Table 83. REGENXBIO Hunter Syndrome Therapeutic Product
Table 84. REGENXBIO Revenue in Hunter Syndrome Therapeutic Business (2018-2023) & (US$ Million)
Table 85. REGENXBIO Recent Development
Table 86. Sangamo Therapeutics Company Detail
Table 87. Sangamo Therapeutics Business Overview
Table 88. Sangamo Therapeutics Hunter Syndrome Therapeutic Product
Table 89. Sangamo Therapeutics Revenue in Hunter Syndrome Therapeutic Business (2018-2023) & (US$ Million)
Table 90. Sangamo Therapeutics Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Hunter Syndrome Therapeutic Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Hunter Syndrome Therapeutic Market Share by Type: 2022 VS 2029
Figure 3. Intravenous Features
Figure 4. Intracerebroventricular (ICV) Features
Figure 5. Global Hunter Syndrome Therapeutic Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 6. Global Hunter Syndrome Therapeutic Market Share by Application: 2022 VS 2029
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Other Case Studies
Figure 10. Hunter Syndrome Therapeutic Report Years Considered
Figure 11. Global Hunter Syndrome Therapeutic Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Hunter Syndrome Therapeutic Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Hunter Syndrome Therapeutic Market Share by Region: 2022 VS 2029
Figure 14. Global Hunter Syndrome Therapeutic Market Share by Players in 2022
Figure 15. Global Top Hunter Syndrome Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hunter Syndrome Therapeutic as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Hunter Syndrome Therapeutic Revenue in 2022
Figure 17. North America Hunter Syndrome Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Hunter Syndrome Therapeutic Market Share by Country (2018-2029)
Figure 19. United States Hunter Syndrome Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Canada Hunter Syndrome Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Hunter Syndrome Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Hunter Syndrome Therapeutic Market Share by Country (2018-2029)
Figure 23. Germany Hunter Syndrome Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. France Hunter Syndrome Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. U.K. Hunter Syndrome Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Italy Hunter Syndrome Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Russia Hunter Syndrome Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Nordic Countries Hunter Syndrome Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Hunter Syndrome Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Hunter Syndrome Therapeutic Market Share by Region (2018-2029)
Figure 31. China Hunter Syndrome Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Japan Hunter Syndrome Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. South Korea Hunter Syndrome Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Southeast Asia Hunter Syndrome Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. India Hunter Syndrome Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Australia Hunter Syndrome Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Hunter Syndrome Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Hunter Syndrome Therapeutic Market Share by Country (2018-2029)
Figure 39. Mexico Hunter Syndrome Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Brazil Hunter Syndrome Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Hunter Syndrome Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Hunter Syndrome Therapeutic Market Share by Country (2018-2029)
Figure 43. Turkey Hunter Syndrome Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Saudi Arabia Hunter Syndrome Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Takeda Revenue Growth Rate in Hunter Syndrome Therapeutic Business (2018-2023)
Figure 46. Denali Therapeutics Revenue Growth Rate in Hunter Syndrome Therapeutic Business (2018-2023)
Figure 47. ArmaGen Revenue Growth Rate in Hunter Syndrome Therapeutic Business (2018-2023)
Figure 48. Inventiva Revenue Growth Rate in Hunter Syndrome Therapeutic Business (2018-2023)
Figure 49. Green Cross Corp Revenue Growth Rate in Hunter Syndrome Therapeutic Business (2018-2023)
Figure 50. CANbridge Life Sciences Ltd. Revenue Growth Rate in Hunter Syndrome Therapeutic Business (2018-2023)
Figure 51. JCR Pharmaceuticals Revenue Growth Rate in Hunter Syndrome Therapeutic Business (2018-2023)
Figure 52. REGENXBIO Revenue Growth Rate in Hunter Syndrome Therapeutic Business (2018-2023)
Figure 53. Sangamo Therapeutics Revenue Growth Rate in Hunter Syndrome Therapeutic Business (2018-2023)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed